Susquehanna Fundamental Investments’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Sell |
15,077
-290,218
| -95% | -$328K | ﹤0.01% | 708 |
|
|
2025
Q1 | $446K | Sell |
305,295
-71,366
| -19% | -$104K | 0.01% | 873 |
|
|
2024
Q4 | $802K | Buy |
+376,661
| New | +$802K | 0.01% | 768 |
|
|
2024
Q2 | $976K | Buy |
418,699
+132,291
| +46% | +$308K | 0.02% | 563 |
|
|
2024
Q1 | $1.28M | Buy |
+286,408
| New | +$1.28M | 0.06% | 305 |
|
|
2023
Q4 | – | Sell |
-161,673
| Closed | -$513K | – | 85 |
|
|
2023
Q3 | $513K | Sell |
161,673
-33,636
| -17% | -$107K | 0.03% | 255 |
|
|
2023
Q2 | $971K | Hold |
195,309
| – | – | 0.04% | 337 |
|
|
2023
Q1 | $965K | Hold |
195,309
| – | – | 0.02% | 524 |
|
|
2022
Q4 | $1.23M | Buy |
+195,309
| New | +$1.23M | 0.02% | 605 |
|
|
2021
Q2 | – | Sell |
-29,657
| Closed | -$1.05M | – | 1644 |
|
|
2021
Q1 | $1.05M | Buy |
+29,657
| New | +$1.05M | 0.02% | 868 |
|